REJOICE-PanTumor01: A Study of Raludotatug Deruxtecan in Participants With Advanced/​Metastatic Solid Tumors

Condition: Endometrial Cancer, Ovarian Cancer, Urothelial Carcinoma, Renal Cell Carcinoma


Go To Trial Homepage